Chemours
415 hedge funds and large institutions have $1.18B invested in Chemours in 2020 Q1 according to their latest regulatory filings, with 63 funds opening new positions, 123 increasing their positions, 126 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
51% less capital invested
Capital invested by funds: $2.4B → $1.18B (-$1.22B)
75% less call options, than puts
Call options by funds: $16.2M | Put options by funds: $63.7M
Holders
415
Holding in Top 10
4
Calls
$16.2M
Puts
$63.7M
Top Buyers
| 1 | +$25.5M | |
| 2 | +$21.9M | |
| 3 | +$21.6M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$10.1M |
| 5 |
SCM
Scopia Capital Management
New York
|
+$7.74M |
Top Sellers
| 1 | -$17.1M | |
| 2 | -$14.3M | |
| 3 | -$12.3M | |
| 4 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
-$10.5M |
| 5 |
MWA
Marshall Wace Asia
Central,
Hong Kong
|
-$7.85M |